HAMMOND | A new partnership between a Hammond medical laboratory and a California-based diagnostics company will expand the lab's testing capabilities, introducing new automation and new equipment.
PCL Alverno and Beckman Coulter Diagnostics recently announced a new installation agreement that will bring more than 150 new instruments to the lab, implementing automation solutions through Beckman Coulter.
"It will allow us to create one of the most automated laboratories," said Sam Terese, president and CEO of Alverno Clinical Laboratories. "It will allow us to continue to grow."
The Hammond lab, a joint venture between Presence Health and Franciscan Alliance, performs more than 750 types of tests in clinical and anatomic pathology.
It processes more than 23 million tests per year. Samples come from local hospitals, physicians, research groups and other clients.
The new partnership is expected to bring new equipment to the lab later in the year, adding to its high-tech tools that include a process for identifying bacteria a day earlier than traditional methods and a system that automates microbiology specimen processing.
"It's about: How can we more effectively deliver care in today's environment?" Terese said.
Instead of being focused solely on the Hammond lab, the new equipment also will impact Franciscan Alliance hospitals in Indianapolis and Presence Health hospitals in Illinois, Terese said.
The partnership is expected to allow Alverno to integrate much more complex molecular testing in the future, he said.
"We are honored that PCL Alverno has chosen to partner with Beckman Coulter Diagnostics to provide solutions that deliver quality results through automation and standardized workflow processes in the laboratory," said John Nosenzo, senior vice president of global customer operations at Beckman Coulter Diagnostics, in a statement. "This partnership demonstrates our shared commitment to patient care and allows us the opportunity to jointly advance and optimize the laboratory – the foundation of patient care."